Emicizumab is well tolerated and effective in people with congenital haemophila A regardless of age severity of disease or inhibitor status a scoping review - G Young; S Pipe; G Kenet; J Oldenburg; E et al; Johnny Mahlangu (WILEY-BLACKWELL, 2024)